Pharma Industry
Industry: Email Alert RSS FeedFDA panel gives partial backing for Cephalon's Provigil, but not sleepiness.
Pharma Marketletter, October, 2003
The US Food and Drug Administration's Peripheral and Central Nervous System Drugs Advisory Committee has backed approval of two new indications for Cephalon's narcolepsy drug Provigil (modafinil), but split down the middle, four-four, on whether the firm should be able to broadly claim the stimulant improves wakefulness in patients with excessive sleepiness associated with disorders of sleep and wakefulness.
Most RecentPharma Articles
Committee members said West Chester, Pennsylvania-based Cephalon had not proven that Provigil was equally effective in every sleep disorder. Panel chairman Claudia Kawas said she worried that, if Cephalon was awarded broad labeling, patients would be given a ...
Brought to you by CBS MoneyWatch.com
- 10 Best Places to Retire
- Companies with the Best 401(k) Plans
- Most Important Document for Your Heirs? It's Not Your Will
- Video: Should You Expect to Retire Rich?
- Over 50? Here's How to Get (and Keep) a Great Job
Most Recent Health Articles
Most Recent Health Publications
Most Popular Health Articles
- Detox in 7 days: a detoux diet can help you shed up to 10 pounds and leave you feeling terrific. Our weeklong plan shows you how to lose the weight and keep it off - Cover story
- All about nightshades: explore the hidden hazards of your favorite food with macrobiotic nutritionist Lino Stanchich
- La anemia falciforme - causas y tratamiento
- The sour truth about apple cider vinegar - evaluation of therapeutic use
- Treat sinusitis naturally: breath easy and relieve sinus pressure with these remedies - Quick Fixes and Long-Term Solutions

